Skip to content

13F-HR filed by TOCQUEVILLE ASSET MANAGEMENT L.P.

TOCQUEVILLE ASSET MANAGEMENT L.P. filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-09, with 513 holding rows worth $5,265,292,419.

Accession
0000919574-23-006048
Filed
2023-11-09
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2023

A holdings report, 513 entries on the cover page, a total value of $5,265,292,419 stated on the cover page (in dollars after the unit check, H1), rows summing to $5,265,292,419 with VALUE read as dollars as filed, 13F file number 028-03589. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
GRUPO TELEVISA S A B40049J206SPON ADR REP ORD26,900$82,045dollars as filed
ORASURE TECHNOLOGIES INC68554V108COM12,600$74,718dollars as filed
COMPUGEN LTDM25722105ORD76,500$71,145dollars as filed
GLATFELTER CORP377320106COMMON STOCK32,025$64,050dollars as filed
EXSCIENTIA PLC30223G102ADS12,900$58,308dollars as filed
IMMIX BIOPHARMA INC45258H106COMMON STOCK12,000$41,040dollars as filed
ZEVIA PBC98955K104CL A15,000$33,300dollars as filed
ASSERTIO HOLDINGS INC04546C205COM NEW10,589$27,108dollars as filed
MEDICENNA THERAPEUTICS F58490H107FOREIGN CANADIAN79,000$23,297dollars as filed
LUMEN TECHNOLOGIES INC550241103COM14,000$19,880dollars as filed
EIGER BIOPHARMACEUTICALS INC28249U105COM51,075$15,578dollars as filed
ACURX PHARMACEUTICALS INC00510M104COM10,100$15,150dollars as filed
SANGAMO THERAPEUTICS INC800677106COM14,780$8,865dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000919574-23-006048this filing2023-11-09acceptance time not in the bulk data set